{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:06:11Z","timestamp":1779152771664,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity and type 2 diabetes (T2D) each independently increase cancer risk, but their combined impact is less understood. With rising early-onset obesity, T2D, and cancer in younger populations, we assessed how diagnoses of both obesity and T2D affect adiposity-related cancer incidence compared to each condition alone, focussing on age-specific trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective (real-world) cohort analysis in a large global federated database (TriNetX, Cambridge MA, USA). Three cohorts were generated and compared with a reference arm, patients without obesity or T2D: cohort 1\u2014patients with obesity, without T2D; cohort 2\u2014patients with T2D, without obesity, and cohort 3\u2014patients with both obesity and T2D. Cohorts underwent propensity score matching (PSM) 1:1 of confounders. We examined 5-year rates of incident cancer (including thirteen (traditional) adiposity-related cancers and an expanded list of 24 adiposity-related cancers), performing stratified analyses by age (younger, middle-aged, and older adults (&lt;\u200940, 40\u201360,\u2009&gt;\u200960\u00a0years), respectively), ethnicity (white, and non-white), and sex (male and female).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After PSM, we compared 2,655,891 people with only obesity, 290,965 with only T2D and 705,499 people with both obesity and T2D, against the reference (1:1). The highest risk was observed in patients with both obesity and T2D (traditional cancers (HR 1.48 [95% CI 1.15, 1.51]) and all adiposity-related cancers (1.30 [1.27, 1.32])). T2D increased the risk of both traditional (1.35 [1.31, 1.39]) and all adiposity-related cancers (1.27 [1.23, 1.31]) to a greater extent than obesity only (increased risk of traditional adiposity-related cancers (1.07 [1.05, 1.09]), but not all adiposity-related cancers (0.99 [0.98, 1.01]). Concerningly, the highest risk of all traditional and adiposity-related cancers was seen in younger (&lt;\u200940\u00a0years) adults with obesity and T2D (1.40 [1.10, 1.79] and 1.58 [1.21, 2.05], respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Risk of incident adiposity-related cancer is driven most strongly by the combination of obesity and T2D, versus either alone, across all age groups, including those with early-onset disease. The impact of early-onset obesity and T2D provides a critical public health problem that demands targeted screening and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04842-8","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T03:49:24Z","timestamp":1776052164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic effects of obesity and type 2 diabetes on adiposity-related cancer risk across age strata"],"prefix":"10.1186","volume":"24","author":[{"given":"Alex E.","family":"Henney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Heague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uazman","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"9793","key":"4842_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","volume":"378","author":"BA Swinburn","year":"2011","unstructured":"Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804\u201314.","journal-title":"Lancet"},{"key":"4842_CR2","doi-asserted-by":"publisher","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers (Basel). 2023;15(2)485. https:\/\/doi.org\/10.3390\/cancers15020485. PMID: 36672434; PMCID: PMC9857053.","DOI":"10.3390\/cancers15020485"},{"issue":"1","key":"4842_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","volume":"16","author":"M Arnold","year":"2015","unstructured":"Arnold M, Pandeya N, Byrnes G, Renehan PAG, Stevens GA, Ezzati PM, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16(1):36\u201346.","journal-title":"Lancet Oncol"},{"issue":"6","key":"4842_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jama.2013.13805","volume":"310","author":"CJ Murray","year":"2013","unstructured":"Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, et al. The state of US health, 1990\u20132010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591\u2013608.","journal-title":"JAMA"},{"issue":"8","key":"4842_CR5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer--viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794\u20138.","journal-title":"N Engl J Med"},{"key":"4842_CR6","doi-asserted-by":"publisher","unstructured":"Keum N, Greenwood DC, Lee DH, Kim R, Aune D, Ju W, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst. 2015;107(2):djv088. https:\/\/doi.org\/10.1093\/jnci\/djv088. PMID: 25757865.","DOI":"10.1093\/jnci\/djv088"},{"issue":"1","key":"4842_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.70071","volume":"21","author":"H Zhu","year":"2026","unstructured":"Zhu H, Yi X, He M, Wu S, Li M, Gao S. Childhood obesity and age-related diseases: a systematic review and meta-analysis of Mendelian Randomization Evidence. Pediatr Obes. 2026;21(1):e70071.","journal-title":"Pediatr Obes"},{"issue":"3","key":"4842_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41366-020-0519-5","volume":"44","author":"S Chadid","year":"2020","unstructured":"Chadid S, Kreger BE, Singer MR, Loring Bradlee M, Moore LL. Anthropometric measures of body fat and obesity-related cancer risk: sex-specific differences in Framingham Offspring Study adults. Int J Obes (Lond). 2020;44(3):601\u20138.","journal-title":"Int J Obes (Lond)"},{"key":"4842_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.","journal-title":"BMJ"},{"issue":"6","key":"4842_CR10","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","volume":"30","author":"J Pearson-Stuttard","year":"2021","unstructured":"Pearson-Stuttard J, Papadimitriou N, Markozannes G, Cividini S, Kakourou A, Gill D, et al. Type 2 diabetes and cancer: an umbrella review of observational and Mendelian Randomization Studies. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1218\u201328.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"4842_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S2213-8587(20)30431-9","volume":"9","author":"J Pearson-Stuttard","year":"2021","unstructured":"Pearson-Stuttard J, Bennett J, Cheng YJ, Vamos EP, Cross AJ, Ezzati M, et al. Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 2021;9(3):165\u201373.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4842_CR12","doi-asserted-by":"publisher","unstructured":"Misra S, Ke C, Srinivasan S, Goyal A, Nyriyenda MJ, Florez JC, Khunti K, Magliano DJ, Luk A. Current insights and emerging trends in early-onset type 2 diabetes. Lancet Diabetes Endocrinol. 2023;(10):768\u201382. https:\/\/doi.org\/10.1016\/S2213-8587(23)00225-5. Epub 2023 Sep 11. PMID: 37708901.","DOI":"10.1016\/S2213-8587(23)00225-5"},{"issue":"2","key":"4842_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, et al. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6(2):ooad035.","journal-title":"JAMIA Open"},{"key":"4842_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101110","volume":"46","author":"MJ Gunter","year":"2024","unstructured":"Gunter MJ, Berrington de Gonzalez A. Is obesity a cause of all cancer types? Lancet Reg Health Eur. 2024;46:101110.","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"4842_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"issue":"7624","key":"4842_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"Ev Elm","year":"2007","unstructured":"Elm Ev, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806.","journal-title":"BMJ"},{"issue":"7","key":"4842_CR17","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/bjc.2016.37","volume":"114","author":"C Garc\u00eda-Jim\u00e9nez","year":"2016","unstructured":"Garc\u00eda-Jim\u00e9nez C, Guti\u00e9rrez-Salmer\u00f3n M, Chocarro-Calvo A, Garc\u00eda-Martinez JM, Casta\u00f1o A, De la Vieja A. From obesity to diabetes and cancer: epidemiological links and role of therapies. Br J Cancer. 2016;114(7):716\u201322.","journal-title":"Br J Cancer"},{"issue":"4","key":"4842_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/jnci\/djad008","volume":"115","author":"M Sun","year":"2023","unstructured":"Sun M, Fritz J, H\u00e4ggstr\u00f6m C, Bj\u00f8rge T, Nagel G, Manjer J, et al. Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study. J Natl Cancer Inst. 2023;115(4):456\u201367.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"4842_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S2213-8587(21)00088-7","volume":"9","author":"R Caleyachetty","year":"2021","unstructured":"Caleyachetty R, Barber TM, Mohammed NI, Cappuccio FP, Hardy R, Mathur R, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2021;9(7):419\u201326.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"4842_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne C, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691.","journal-title":"Gut"},{"issue":"1","key":"4842_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61563-9","volume":"14","author":"T Laurberg","year":"2024","unstructured":"Laurberg T, Witte DR, Gudbj\u00f6rnsdottir S, Eliasson B, Bjerg L. Diabetes-related risk factors and survival among individuals with type 2 diabetes and breast, lung, colorectal, or prostate cancer. Sci Rep. 2024;14(1):10956.","journal-title":"Sci Rep"},{"issue":"9","key":"4842_CR22","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.2337\/dc20-0204","volume":"43","author":"S Ling","year":"2020","unstructured":"Ling S, Brown K, Miksza JK, Howells L, Morrison A, Issa E, et al. Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People. Diabetes Care. 2020;43(9):2313\u201322.","journal-title":"Diabetes Care"},{"key":"4842_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.","journal-title":"BMJ"},{"issue":"9","key":"4842_CR24","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00125-020-05228-y","volume":"63","author":"EE Vincent","year":"2020","unstructured":"Vincent EE, Yaghootkar H. Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence? Diabetologia. 2020;63(9):1706\u201317.","journal-title":"Diabetologia"},{"issue":"5","key":"4842_CR25","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ijc.27719","volume":"132","author":"Y Yang","year":"2013","unstructured":"Yang Y, Dong J, Sun K, Zhao L, Zhao F, Wang L, et al. Obesity and incidence of lung cancer: a meta-analysis. Int J Cancer. 2013;132(5):1162\u20139.","journal-title":"Int J Cancer"},{"issue":"3","key":"4842_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2337\/cd19-0077","volume":"38","author":"PR Bonagiri","year":"2020","unstructured":"Bonagiri PR, Shubrook JH. Review of associations between type 2 diabetes and cancer. Clin Diabetes. 2020;38(3):256\u201365.","journal-title":"Clin Diabetes"},{"issue":"1","key":"4842_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2337\/dc22-1575","volume":"46","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Song M, Cao Y, Eliassen AH, Wolpin BM, Stampfer MJ, et al. Incident early- and later-onset type 2 diabetes and risk of early- and later-onset cancer: prospective cohort study. Diabetes Care. 2022;46(1):120\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"4842_CR28","first-page":"158","volume":"41","author":"K Calkins","year":"2011","unstructured":"Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care. 2011;41(6):158\u201376.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"7","key":"4842_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21305","volume":"7","author":"L Wang","year":"2024","unstructured":"Wang L, Xu R, Kaelber DC, Berger NA. Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes. JAMA Netw Open. 2024;7(7):e2421305.","journal-title":"JAMA Netw Open"},{"key":"4842_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2025.100175","volume":"15","author":"S Christensen","year":"2025","unstructured":"Christensen S, Nelson C. Chronicity of obesity and the importance of early treatment to reduce cardiometabolic risk and improve body composition. Obes Pillars. 2025;15:100175.","journal-title":"Obes Pillars"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04842-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04842-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:11:42Z","timestamp":1779149502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04842-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4842"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04842-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8237970\/v1","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study is exempt from informed consent. The data reviewed is a secondary analysis of existing data, does not involve intervention or interaction with human subjects, and is de-identified per the de-identification standard defined in Section \u00a7164.514(a) of the HIPAA Privacy Rule. The process by which the data is de-identified is attested to through a formal determination by a qualified expert as defined in Section \u00a7164.514(b)(1) of the HIPAA Privacy Rule. This formal determination by a qualified expert refreshed on December 2020.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors and contributing third parties (TriNetX) consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DJC has received investigator-initiated grants from Astra Zeneca and Novo Nordisk, support for education from Perspectum and financial remuneration for consultancy work from pharmaceutical company consultation (Madrigal, Roche) with all payments made to the University of Liverpool. He also serves as the Topic Advisor for Type 2 Diabetes medications for The National Institute for Health and Care Excellence (NICE), UK. UA has received honoraria from Procter & Gamble, Viatris, Grunenthal and Sanofi for educational meetings and funding for attendance to an educational meeting from Diiachi Sankyo. UA has also received investigator-led funding by Procter & Gamble and is a council member of the Royal Society of Medicine\u2019s Vascular, Lipid & Metabolic Medicine Section. All other authors (AEH and MH) declare that there are no financial relationships or activities that might bias, or be perceived to bias, their contribution to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}